Skip to content
Screener

CeriBell, Inc. CBLL Financing Cash Flow

Financing Cash Flow at other companies

IAR
Integra LifeSciencesIART
$8.3M-76.5%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$1.85M-35.5%
iRadimed logo
iRadimedIRMD
-$2.61M-14.4%
Teladoc Health logo
Teladoc HealthTDOC
-$2.45M-418%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$4.08M-42.5%
ICU Medical logo
ICU MedicalICUI
-$50.24M+74.2%

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Cash flows from financing activities
Proceeds related to employee stock plans2,5122,158
Debt issuance cost(150)
Net cash provided by financing activities2,5122,008
Net increase (decrease) in cash and cash equivalents(7,813)(154,229)
Cash and cash equivalents, beginning of period40,476194,370
Cash and cash equivalents, end of period$32,663$40,141
Supplemental disclosure of cash flow information

Item 1. Financial Statements.

FAQ

What is CeriBell, Inc.'s financing cash flow?
CeriBell, Inc. (CBLL) reported financing cash flow of $880K in Q2 2026.
How has CeriBell, Inc.'s financing cash flow changed year-over-year?
CeriBell, Inc.'s financing cash flow decreased by 56.1% year-over-year, from $2.01M to $880K.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about CeriBell, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude